Atria Investments LLC Cardiol Therapeutics Inc. Transaction History
Atria Investments LLC
- $7.33 Billion
- Q1 2025
A detailed history of Atria Investments LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Atria Investments LLC holds 139,053 shares of CRDL stock, worth $161,301. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,053
Previous 135,891
2.33%
Holding current value
$161,301
Previous $175,000
23.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
7.84MCall Options Held
25.9KPut Options Held
1.7K-
Tejara Capital LTD London, X03.19MShares$3.71 Million1.2% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD982KShares$1.14 Million0.19% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9783KShares$907,8440.35% of portfolio
-
Ubs Group Ag498KShares$577,5140.0% of portfolio
-
Pvg Asset Management Corp Golden, CO437KShares$507,3391.99% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $71.9M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...